Jason Marcell Foster MD
Surgical Oncology (Other than Breast)
Associate Professor, Surgery, University of Nebraska Medical Center College
Join to View Full Profile
601 N 30th St Ste 2803Omaha, NE 68131
Phone+1 402-280-4100
Fax+1 402-552-2512
Are you Dr. Foster?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jason Foster, MD is a general surgeon in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, New York, and Ohio. He is an Associate Professor at University of Nebraska Medical Center College.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1994 - 2002
Lewis Katz School of Medicine at Temple UniversityClass of 1994
Certifications & Licensure
NE State Medical License 2005 - 2026
NY State Medical License 2002 - 2007
OH State Medical License 1996 - 2005
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Safety and Efficacy of Initiating Parenteral Nutrition at Home, Home Start PN, in Advanced Peritoneal Metastasis.Chunmeng Zhang, Ujwal Yanala, Mounika Addula, Sherry Adams, Louise Ocken
Cancers. 2024-12-23 - Recognizing Systemic (Not Peritoneal) Recurrence May Drive Survival After Optimal Resection of Colorectal Peritoneal Metastasis (CRC-PM) and the Quest for the Surrogat...Jason M Foster, Domenico Sabia, Lana Bijelic
Annals of Surgical Oncology. 2024-12-01 - How Many Sentinel Lymph Nodes Should We Excise in Patients With Melanoma?Jason M Lizalek, Collin E Dougherty, Bradley N Reames, Jason Foster, Juan A Santamaria
The Journal of Surgical Research. 2024-11-01
Press Mentions
Surgery/HIPEC Safer Than Other High-Risk Cancer ProceduresJanuary 15th, 2019
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy Compared with Other High-Risk Surgical Oncology ProceduresJanuary 4th, 2019
